SNU-5 In Vitro Protein Expression Analysis Assay (Immunoassays)

This assay is to provide SNU-5-based In Vitro Protein Expression Analysis Assay (Immunoassays) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.

SNU-5

Human

SNU-5 was line derived in 1987 by J. Park and associates from ascites of a patient with poorly differentiated carcinoma of the stomach. The patient had previously received chemotherapy including 5-fluorouracil, doxorubicin and mitomycin-C.
Derived from metastatic site, ascites

Gastric Carcinoma

Oncology

In Vitro Protein Expression Analysis Assay (Immunoassays)

SNU-5-cell based In Vitro Protein Expression Analysis Assay (Immunoassays)

For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis

Gene and Protein Expression Assays

Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.